Cancer detection firm Freenome to go public via $330 million SPAC deal Company part of competitive race to spot disease early through blood-based tests

https://www.statnews.com/2025/12/05/freenome-plans-go-public-early-cancer-detection/ By Jonathan WosenDec. 5, 2025 West Coast Biotech & Life Sciences Reporter